Hyperphosphatemia
📧 Sign up to get email alerts when something new happens for Hyperphosphatemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis [Phase 3]
This report covers a long-term safety extension of ferric citrate in adults with end-stage renal disease on dialysis, part of a Phase 3 prog…
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: Efficacy of Dietary Education and Education on Phosphate Binder Use in Hemodialysis Patients [NA]
A completed clinical trial evaluated whether dietary education and training on phosphate binder use improve phosphate control in hemodialysi…
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients [Phase 3]
This clinical trial update reports the Phase 3 open study of lanthanum carbonate (BAY77-1931) in continuous ambulatory peritoneal dialysis p…
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects [Phase 1]
Phase 1 study assessed whether Colestilan affects the pharmacokinetics of a single dose of candesartan cilexetil in healthy subjects. The tr…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules [Phase 2, Phase 3]
The trial evaluated therapeutic equivalence between OsvaRen tablets and OsvaRen granules in hyperphosphatemia associated with chronic kidney…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Safety and Tolerability Study of MCI-196 [Phase 3]
Phase 3 safety and tolerability study of MCI-196 in chronic kidney disease patients, including those not on dialysis and paediatric populati…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Dose-finding Study of MCI-196 [Phase 3]
Phase 3 dose-finding study of MCI-196 sponsored by Tanabe Pharma has been terminated. The trial investigated MCI-196 in chronic kidney disea…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Long-term Extension Study of MCI-196 [Phase 3]
A terminated Phase 3 long-term extension study of MCI-196 in chronic kidney disease patients; the trial status has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis [Phase 3]
A Phase 3 long-term study in patients with chronic kidney disease and hyperphosphatemia on hemodialysis has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Long-term Study in Chronic Kidney Disease (Extension From Study 14817) [Phase 3]
This entry notes the completion of a long-term extension of a Phase 3 trial in hyperphosphatemia associated with chronic kidney disease spon…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis [Phase 3]
A Phase 3 randomized, double-blind, placebo-controlled trial evaluating sevelamer carbonate for hyperphosphatemia in non-dialysis chronic ki…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With Hyperphosphataemia
Post-authorization safety study of Renvela (sevelamer carbonate) in chronic kidney disease patients not on dialysis with hyperphosphatemia h…
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis [Phase 3]
An open-label, dose-titration Phase 3 study evaluating sevelamer carbonate in hyperphosphatemic CKD patients not on dialysis has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Effect of Restriction of Foods Containing Phosphorus Additives [NA]
A completed clinical trial evaluating the impact of restricting foods containing phosphorus additives in patients with end-stage renal disea…
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis [Phase 3]
A 58-week Phase 3 trial evaluating the safety and efficacy of Ferric Citrate in patients with end-stage renal disease on dialysis for hyperp…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease [Phase 3]
Phase 3 dose-ranging trial of ferric citrate (KRX-0502) in end-stage renal disease patients with hyperphosphatemia. Results from the study h…
-
CLINICAL_TRIALS trial_result · 2014-11-18Clinical Trial Update: Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
Completed clinical trial evaluating a new formulation of ferric citrate (KRX-0502) for hyperphosphatemia in patients with end-stage renal di…
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia [Phase 3]
Phase III, multicenter, double-blind, placebo-controlled withdrawal study in patients with hyperphosphatemia related to chronic kidney disea…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Study in Chronic Kidney Disease (CKD) Not on Dialysis [Phase 3]
A Bayer-sponsored Phase 3 trial in chronic kidney disease patients not on dialysis evaluating treatment for hyperphosphatemia has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD) [Phase 2]
Phase 2 safety and tolerability results for ferric citrate (Zerenex) in patients with end-stage renal disease and hyperphosphatemia; the tri…
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia [Phase 3]
Phase 3 trial of MCI-196 in chronic kidney disease patients on dialysis with hyperphosphatemia and dyslipidemia completed; results posted in…
-
CLINICAL_TRIALS trial_result · 2014-09-23Clinical Trial Update: A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia [Phase 3]
Phase 3 study of MCI-196 in chronic kidney disease patients on dialysis with hyperphosphatemia completed; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-18Clinical Trial Update: Phosphate Kinetic Modeling 2 [Phase 4]
This update notes the completion of a Phase 4 clinical trial called Phosphate Kinetic Modeling 2, sponsored by Fresenius Medical Care North …
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients [Phase 4]
Phase 4 long-term evaluation comparing sevelamer hydrochloride with a calcium-based phosphate binder in hyperphosphatemia among hemodialysis…
-
CLINICAL_TRIALS trial_result · 2014-07-25Clinical Trial Update: A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia [Phase 3]
A Phase 3, randomized, double-blind, placebo-controlled withdrawal study of MCI-196 in chronic kidney disease patients on dialysis with hype…